Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1980 3
1982 2
1983 2
1985 1
1986 3
1987 1
1988 3
1989 1
1990 5
1991 6
1992 16
1993 18
1994 34
1995 18
1996 21
1997 24
1998 8
1999 1
2000 2
2001 4
2002 3
2003 2
2004 6
2005 5
2006 8
2007 6
2008 7
2009 7
2010 3
2011 5
2012 4
2014 2
2015 2
2016 1
2017 4
2018 5
2019 8
2020 4
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

258 results
Results by year
Filters applied: . Clear all
Page 1
Gene expression profiling predicts clinical outcome of breast cancer.
van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. van 't Veer LJ, et al. Among authors: linsley ps. Nature. 2002 Jan 31;415(6871):530-6. doi: 10.1038/415530a. Nature. 2002. PMID: 11823860
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Herold KC, Bundy BN, Long SA, Bluestone JA, DiMeglio LA, Dufort MJ, Gitelman SE, Gottlieb PA, Krischer JP, Linsley PS, Marks JB, Moore W, Moran A, Rodriguez H, Russell WE, Schatz D, Skyler JS, Tsalikian E, Wherrett DK, Ziegler AG, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group. Herold KC, et al. Among authors: linsley ps. N Engl J Med. 2019 Aug 15;381(7):603-613. doi: 10.1056/NEJMoa1902226. Epub 2019 Jun 9. N Engl J Med. 2019. PMID: 31180194 Free PMC article. Clinical Trial.
Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy.
Sheih A, Voillet V, Hanafi LA, DeBerg HA, Yajima M, Hawkins R, Gersuk V, Riddell SR, Maloney DG, Wohlfahrt ME, Pande D, Enstrom MR, Kiem HP, Adair JE, Gottardo R, Linsley PS, Turtle CJ. Sheih A, et al. Among authors: linsley ps. Nat Commun. 2020 Jan 10;11(1):219. doi: 10.1038/s41467-019-13880-1. Nat Commun. 2020. PMID: 31924795 Free PMC article. Clinical Trial.
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.
Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobayashi SV, Linsley PS, Thompson CB, Riley JL. Parry RV, et al. Among authors: linsley ps. Mol Cell Biol. 2005 Nov;25(21):9543-53. doi: 10.1128/MCB.25.21.9543-9553.2005. Mol Cell Biol. 2005. PMID: 16227604 Free PMC article.
Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.
Perdigoto AL, Preston-Hurlburt P, Clark P, Long SA, Linsley PS, Harris KM, Gitelman SE, Greenbaum CJ, Gottlieb PA, Hagopian W, Woodwyk A, Dziura J, Herold KC; Immune Tolerance Network. Perdigoto AL, et al. Among authors: linsley ps. Diabetologia. 2019 Apr;62(4):655-664. doi: 10.1007/s00125-018-4786-9. Epub 2018 Dec 19. Diabetologia. 2019. PMID: 30569273 Free PMC article.
A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders.
Wambre E, Bajzik V, DeLong JH, O'Brien K, Nguyen QA, Speake C, Gersuk VH, DeBerg HA, Whalen E, Ni C, Farrington M, Jeong D, Robinson D, Linsley PS, Vickery BP, Kwok WW. Wambre E, et al. Among authors: linsley ps. Sci Transl Med. 2017 Aug 2;9(401):eaam9171. doi: 10.1126/scitranslmed.aam9171. Sci Transl Med. 2017. PMID: 28768806 Free PMC article. Clinical Trial.
CTLA-4 can function as a negative regulator of T cell activation.
Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA. Walunas TL, et al. Among authors: linsley ps. Immunity. 1994 Aug;1(5):405-13. doi: 10.1016/1074-7613(94)90071-x. Immunity. 1994. PMID: 7882171
Oncostatin M.
Bruce AG, Linsley PS, Rose TM. Bruce AG, et al. Among authors: linsley ps. Prog Growth Factor Res. 1992;4(2):157-70. doi: 10.1016/0955-2235(92)90029-h. Prog Growth Factor Res. 1992. PMID: 1338575 Review.
258 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page